Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Center for Molecular Oncology and Division of Endocrinology & Metabolism, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Endocr Relat Cancer. 2020 Aug;27(8):T53-T63. doi: 10.1530/ERC-20-0018.
This report summarizes published data on parathyroid cancer, with the inclusion of topics discussed at MEN2019: 16th International Workshop on Multiple Endocrine Neoplasia, 27-29 March 2019, Houston, TX, USA. An expert panel on parathyroid cancer was constituted by the Steering Committee to address key questions in the field. The objectives were to recap open forum discussion of interested parties from multiple disciplines. The expert panel met in a closed session to consult on the data to be highlighted on the evidence-based results and on the future directions. Preceding the Conference, members of the expert panel conducted an extensive literature search. All presentations were based upon the best peer-reviewed information taking into account the historical and current literature. Questions were developed by the expert panel on parathyroid carcinoma. A comprehensive literature search for relevant studies was undertaken. This report represents the expert panel's synthesis of the conference material placed in a context designed to be relevant to clinicians and those engaged in cutting-edge studies of parathyroid carcinoma. This document not only provides a summary of our current knowledge but also places recent advances in its management into a context that should enhance future advances in our understanding of parathyroid carcinoma.
本报告总结了已发表的甲状旁腺癌文献资料,其中包括 2019 年 3 月 27 日至 29 日在美国德克萨斯州休斯顿举行的第 16 届多发性内分泌肿瘤国际研讨会(MEN2019)上讨论的主题。一个甲状旁腺癌专家小组由指导委员会组建,以解决该领域的关键问题。目标是总结来自多个学科的利益相关方公开论坛讨论的情况。专家小组在一次闭门会议上开会,就基于证据的结果要突出显示的数据以及未来的方向进行磋商。在会议之前,专家小组成员进行了广泛的文献检索。所有演讲均基于最佳同行评议信息,同时考虑到历史和当前文献。甲状旁腺癌专家小组提出了问题。对相关研究进行了全面的文献检索。本报告代表了专家小组对会议材料的综合,其内容旨在与临床医生和从事甲状旁腺癌前沿研究的人员相关。本文件不仅提供了我们当前知识的总结,而且将最近在其管理方面的进展置于一个应该促进我们对甲状旁腺癌理解的未来进展的背景下。